Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Evolus (EOLS) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 14 quarters since 2018. Compare with EOLS stock chart to see long term trends.

EOLS stock compared to

EOLS Income Statement

Revenue, Net:26098000
Revenue Per Share:0.48
Cost of Goods & Services Sold:11302000
Selling, General & Admin Expense:26472000
Research & Development Expense:499000
Total Operating Expenses:41400000
Operating Income:-15601000
Income Taxes:0
Net Income:-15601000
Earnings Per Share, Basic:-0.31
Shares Outstanding, Basic Avg:54576156

EOLS Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:1746000
Change in Accounts Receiveable:3751000
Net Cash from Operations:16116000
Net Cash from Financing Activities:93836000
Property, Plant & Equipment Purchases:0
Net Cash from Investing Activities:-386000
Net Change in Cash & Equivalents:109566000

EOLS Balance Sheet

Cash and Cash Equivalents:131737000
Accounts Receivable, Net:11864000
Inventories:3337000
Total Current Assets:161890000
Property, Plant & Equipment, Net:1137000
Total Assets:239863000
Accounts Payable:8059000
Total Short-Term Liabilities:87286000
Total Liabilities:133725000

Insider Trading

Change
Value
Transaction
SEC Form 4
Medytox Inc.   10% Owner
51,000 sh at $11
$557,568
Buy
Medytox Inc.   10% Owner
103,000 sh at $11
$1,084,808
Buy
Medytox Inc.   10% Owner
115,000 sh at $11
$1,222,137
Buy
Medytox Inc.   10% Owner
114,714 sh at $11
$1,282,751
Buy
Medytox Inc.   10% Owner
65,286 sh at $11
$709,452
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
2,127,366 sh
446,255 sh
27%
$26,912
$5,075
Vanguard Group Inc
1,677,083 sh
547,576 sh
48%
$21,215
$6,543
First Manhattan Co
1,383,000 sh
1,383,000 sh
NEW
$17,494
$17,494
Schroder Investment Management Group
1,359,329 sh
463,730 sh
52%
$17,196
$5,562
Nuveen Asset Management, LLC
601,362 sh
526,591 sh
704%
$7,607
$6,636
Soleus Capital Management, L.P.
580,000 sh
580,000 sh
NEW
$7,337
$7,337
Geode Capital Management, LLC
567,609 sh
184,502 sh
48%
$7,180
$2,204
State Street Corp
537,240 sh
141,825 sh
36%
$6,796
$1,660
Awh Capital, L.P.
515,000 sh
105,000 sh
26%
$6,515
$1,189
D. E. Shaw & Co., Inc.
500,366 sh
337,068 sh
206%
$6,330
$4,208
Tri Locum Partners LP
496,826 sh
415,801 sh
513%
$6,285
$5,232
Marshall Wace, Llp
488,419 sh
220,296 sh
82%
$6,178
$2,695
Schonfeld Strategic Advisors LLC
394,214 sh
394,214 sh
NEW
$4,988
$4,988
Marshall Wace North America L.P.
370,040 sh
335,394 sh
968%
$4,682
$4,233
Marshall Wace North America L.P.
370,040 sh
335,394 sh
968%
$4,682
$4,233
Sg Americas Securities, LLC
351,813 sh
255,670 sh
266%
$4,450
$3,201
Northern Trust Corp
342,773 sh
85,911 sh
33%
$4,336
$999
Goldman Sachs Group Inc
316,377 sh
243,101 sh
332%
$4,002
$3,050
Susquehanna International Group, Llp
296,779 sh
165,479 sh
126%
$3,754
$2,048
Jane Street Group, LLC
Call options for 245,100 sh
245,100 sh
NEW
$3,101
$3,101

Data imported from Evolus Inc SEC filings. Check original filings before making any investment decision.